The effect of intestinal permeability and endotoxemia on the prognosis of acute pancreatitis

Gut and Liver

Volumn 6, Issue 4, 2012, Pages 505-511

  Koh, Young Yool ^a   Jeon, Woo Kyu ^a   Cho, Yong Kyun ^a   Kim, Hong Joo ^a   Chung, Won Gil ^a   Chon, Chang Uk ^a   Oh, Tae Yun ^a   Shin, Jun Ho ^a  

^a School of Medicine   (South Korea)

Author keywords

Acute pancreatitis; Balthazar computed tomography severity index; Cytokines; Endotoxins; Intestinal permeability

Indexed keywords

CYTOKINE; ENDOTOXIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ADULT; APACHE; ARTICLE; COMPUTED TOMOGRAPHY SEVERITY INDEX; CORRELATION ANALYSIS; ENDOTOXEMIA; FEMALE; HUMAN; INTESTINE MUCOSA PERMEABILITY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PROGNOSIS; SCORING SYSTEM;

EID: 84868109563     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2012.6.4.505     Document Type: Article

References (25)

1. Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 2003;18:479-497.
2. Juvonen PO, Tenhunen JJ, Heino AA, et al. Splanchnic tissue perfusion in acute experimental pancreatitis. Scand J Gastroenterol 1999;34:308-314.
3. Cicalese L, Sahai A, Sileri P, et al. Acute pancreatitis and bacterial translocation. Dig Dis Sci 2001;46:1127-1132.
4. Mullin JM, Snock KV. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 1990;50:2172-2176.
5. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-45.
6. O'Dwyer ST, Michie HR, Ziegler TR, Revhaug A, Smith RJ, Wilmore DW. A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 1988;123:1459-1464.
7. Dib M, Zhao X, Wang X, Andersson R. Mast cells contribute to early pancreatitis-induced systemic endothelial barrier dysfunction. Pancreatology 2002;2:396-401.
8. Leveau P, Wang X, Sun Z, Börjesson A, Andersson E, Andersson R. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant. Biochem Pharmacol 2005;69:1325-1331.
9. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990;174:331-336.
10. Gürleyik G, Emir S, Kilicoglu G, Arman A, Saglam A. Computed tomography severity index, APACHE II score, and serum CRP concentration for predicting the severity of acute pancreatitis. JOP 2005;6:562-567.
11. Chatzicostas C, Roussomoustakaki M, Vardas E, Romanos J, Kouroumalis EA. Balthazar computed tomography severity index is superior to Ranson criteria and APACHE II and III scoring systems in predicting acute pancreatitis outcome. J Clin Gastroenterol 2003;36:253-260.
12. Bradley EL 3rd. A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993;128:586-590.
13. Gloor B, Müller CA, Worni M, et al. Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch Surg 2001;136:592-596.
14. Hotz HG, Foitzik T, Rohweder J, et al. Intestinal microcirculation and gut permeability in acute pancreatitis: early changes and therapeutic implications. J Gastrointest Surg 1998;2:518-525.
15. Ammori BJ. Gut barrier dysfunction in patients with acute pancreatitis. J Hepatobiliary Pancreat Surg 2002;9:411-412.
16. Juvonen PO, Alhava EM, Takala JA. Gut permeability in patients with acute pancreatitis. Scand J Gastroenterol 2000;35:1314-1318.
17. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005;41:422-433.
18. Ammori BJ. Role of the gut in the course of severe acute pancreatitis. Pancreas 2003;26:122-129.
19. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-1581.
20. Cox MA, Lewis KO, Cooper BT. Measurement of small intestinal permeability markers, lactulose, and mannitol in serum: results in celiac disease. Dig Dis Sci 1999;44:402-406.
21. Galloway SW, Kingsnorth AN. Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity. Br J Surg 1994;81:312.
22. Inagaki T, Hoshino M, Hayakawa T, et al. Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis. Pancreas 1997;14:1-8.
23. Demydov VM, Zaporozhchenko BS, Demidov SM. Changes of cytokine levels in the serum in patients with acute pancreatitis as an early symptom for diagnosis. Klin Khir 2003:29-32.
24. Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med 1993;21(10 Suppl):S447-S463.
25. Persson J, Berg NO, Sjolund K, Stenling R, Magnusson PH. Morphologic changes in the small intestine after chronic alcohol consumption. Scand J Gastroenterol 1990;25:173-184.